Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: Results of an open label study

European Archives of Psychiatry and Clinical Neuroscience

Volumn 261, Issue 8, 2011, Pages 567-573

  Cordes, Joachim ^a   Kahl, Kai G ^b   Werner, Christian ^c   Henning, Uwe ^a   Regenbrecht, Gunnar ^a   Larisch, Rolf ^d   Schmidt Kraepelin, Christian ^a   Thünker, Johanna ^a   Agelink, Marcus W ^e   Löffler, Stefan ^f   Hohlfeld, Thomas ^d   Gaebel, Wolfgang ^a   Klimke, Ansgar ^f  

^a Department of Orthopedic Surgery   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Otsuka Pharma GmbH   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f NONE   (Germany)

Author keywords

Clomipramine challenge; Homovanillic acid; Monoamine metabolites; Plasma; Prolactin

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; CLOMIPRAMINE; DOPAMINE; HOMOVANILLIC ACID; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; NEUROPHARMACOLOGY; NEUROTRANSMISSION; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PSYCHOPHARMACOTHERAPY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOLOGICAL MARKERS; CLOMIPRAMINE; DOPAMINE; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; INJECTIONS, INTRAVENOUS; MALE; PROLACTIN; SEROTONIN; SEX CHARACTERISTICS;

EID: 84355163130     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-011-0201-y     Document Type: Article

References (46)

1. H Ågren L Terenius 1985 Hallucinations in patients with major depression: interaction between CSF monoaminergic and endorphinergic indices J Affect Disord 9 25 34 2410472 10.1016/0165-0327(85)90006-0 (Pubitemid 15068944)
2. AC Altamura B Dell'Osso HA Berlin M Buoli R Bassetti E Mundo 2010 Duration of untreated illness and suicide in bipolar disorder: a naturalistic study Eur Arch Psychiatry Clin Neurosci 260 5 385 391 19911248 10.1007/s00406-009-0085-2
3. F Amin M Davidson KL Davis 1986 Homovanillic acid measurement in clinical research: a review of methodology Neuropsychobiology 16 2-3 85 87
4. IM Anderson J Ware JM Daroza Davis PJ Cowen 1992 Decreased 5-HT-mediated prolactin release in major depression Br J Psychiatry 160 372 378 1562864 10.1192/bjp.160.3.372 1:STN:280:DyaK383itl2qsw%3D%3D
5. N Ben-Jonathan CR LaPensee EW LaPensee 2008 What can we learn from rodents about prolactin in humans? Endocr Rev 29 1 1 41 18057139 10.1210/er.2007-0017 1:CAS:528:DC%2BD1cXivFGqs7o%3D (Pubitemid 351252745)
6. N Ben-Jonathan C Olivaer HJ Weiner RS Mical JC Porter 1977 Dopamine in hypophysial portal plasma of the rat during the estrous cycle and throughout pregnancy Endocrinology 100 452 458 556691 10.1210/endo-100-2-452 1:CAS:528:DyaE2sXhtVeqsLg%3D (Pubitemid 8033944)
7. RA Bressan K Erlandsson EP Spencer PJ Ell LS Pilowsky 2004 Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients Psychopharmacology 175 3 367 373 14997280 10.1007/s00213-004- 1826-6 1:CAS:528:DC%2BD2cXotVOhsb8%3D (Pubitemid 39361925)
8. LL Carpenter GM Anderson JM Siniscalchi PB Chappell LH Price 2003 Acute changes in cerebrospinal fluid 5-HIAA following oral paroxetine challenge in healthy humans Neuropsychopharmacology 28 2 339 347 12589387 10.1038/sj.npp.1300025 1:CAS:528:DC%2BD3sXhtFGhsL0%3D
9. J Cordes R Larisch U Henning J Thünker C Werner G Orozco F Mayoral F Rivas G Auburger M Tosch M Rietschel W Gaebel H-W Müller A Klimke 2009 Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis Depression Anxiety 26 8 E111 E119 10.1002/da.20405
10. KT Demarest GD Riegle KE Moore 1984 Adenohypophysial dopamine content during physiological changes in prolactin secretion Endocrinology 115 6 2091 2097 6541994 10.1210/endo-115-6-2091 1:CAS:528:DyaL2MXktVCnug%3D%3D (Pubitemid 15186240)
11. JD Elsworth DE Redmond Jr RH Roth 1982 Plasma and cerebrospinal fluid 3-methoxy-4-hydroxy-phenylethyleneglycol (MHPG) as indices of brain norepinephrine metabolism in primates Brain Res 235 115 124 7188317 10.1016/0006-8993(82)90200-1 1:CAS:528:DyaL38XhsFKgsL0%3D (Pubitemid 12188132)
12. J Endicott RL Spitzer 1978 A diagnostic interview: The schedule for affective disorders and schizophrenia Arch Gen Psychiatry 35 837 844 678037 1:STN:280:DyaE1c3jsVGiug%3D%3D (Pubitemid 9076798)
13. ME Freeman B Kanyicska A Lerant G Nagy 2000 Prolactin: structure, function, and regulation of secretion Physiol Rev 80 4 1523 1631 11015620 1:CAS:528:DC%2BD3cXnsVKisLY%3D
14. Fujita K, Kobayashi A, Suzuki S, Nakazawa K (1991) Changes of serotonin and catecholamines are related to pharmacokinetic alterations of clomipramine in rat brain. Eur J Pharmacol 12; 204(3):227-233
15. PK Gillman 2007 Tricyclic antidepressant pharmacology and therapeutic drug interactions updated Br J Pharmacol 151 6 737 748 17471183 10.1038/sj.bjp.0707253 1:CAS:528:DC%2BD2sXns1ylsbc%3D (Pubitemid 47075311)
16. RN Golden J Hsiao E Lane R Hicks S Rogers WZ Potter 1989 The effects of intravenous clomipramine on neurohormones in normal subjects J Clin Endocrinol Metab 68 632 2537340 10.1210/jcem-68-3-632 1:CAS:528:DyaL1MXhsVyntL4%3D
17. RN Golden J Hsiao E Lane D Ekstrom S Rogers R Hicks WZ Potter 1990 Abnormal neuroendocrine responsivity to acute intravenous clomipramine challenge in depressed patients Psychiatry Res 31 1 39 47 2156276 10.1016/0165-1781(90) 90107-G 1:CAS:528:DyaK3cXhsFWlur4%3D (Pubitemid 20049543)
18. RN Golden D Ekstrom TM Brown R Ruegg DL Evans JJ Haggerty Jr JC Garbutt CA Pedersen GA Mason J Browne SW Carson 1992 Neuroendocrine effect of intravenous clomipramine in depressed patients and healthy subjects Am J Psychiatry 149 9 1168 1175 1323933 1:STN:280:DyaK38zmslOrtQ%3D%3D
19. RN Golden AD Heine RD Ekstrom JM Bebchuk ME Leatherman JC Garbutt 2002 A longitudinal study of serotonergic function in depression Neuropsychopharmacology 26 5 653 659 11927190 10.1016/S0893-133X(01)00406-7 1:CAS:528:DC%2BD38Xitlaqsrw%3D (Pubitemid 34260984)
20. RN Golden JH Gilmore RD Ekstrom B Knight RG Ruegg HL Miller SW Carson 1996 The effects of age, gender, and season on serotonergic function in healthy subjects Prog Neuropsychopharmacol Biol Psychiatry 20 8 1315 1323 9004339 10.1016/S0278-5846(96)00128-5 1:STN:280:DyaK2s7lvVSlsg%3D%3D (Pubitemid 26412836)
21. RN Gupta C Whelton 1992 Determination of plasma homovanillic acid by liquid chromatography with electrochemical detection J Chromatogr 582 236 241 1491047 10.1016/0378-4347(92)80325-K 1:CAS:528:DyaK3sXptlQ%3D
22. J Jokinen AL Nordström P Nordström 2007 The relationship between CSF HVA/5-HIAA ratio and suicide intent in suicide attempters Arch Suicide Res 11 2 187 192 17453696 10.1080/13811110701250093
23. S Kapur X Langlois P Vinken AA Megens R De Coster JS Andrews 2002 The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats J Pharmacol Exp Ther 302 3 1129 1134 12183672 10.1124/jpet.102.035303 1:CAS:528:DC%2BD38XmsF2htrY%3D (Pubitemid 34920235)
24. AH Kemp E Gordon AJ Rush LM Williams 2008 Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures CNS Spectr 13 12 1066 1086 19179943
25. Larisch R, Klimke A, Hamacher K, Henning U, Estalji S, Hohlfeld T, Vosberg H, Tosch M, Gaebel W, Coenen HH, Müller-Gärtner HW (2003) Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man. Behav Brain Res 17; 139(1-2):21-9
26. GM MacQueen 2009 (2009) Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder J Psychiatry Neurosci 34 5 343 349 19721844
27. JJ Mann D Currier 2007 A review of prospective studies of biologic predictors of suicidal behavior in mood disorders Arch Suicide Res 11 1 3 16 17178639 10.1080/13811110600993124
28. M Markianos J Hatzimanolis L Lykouras 2002 Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course Eur Arch Psychiatry Clin Neurosci 252 4 172 176 12242578 (Pubitemid 36056673)
29. McBride PA, Tierney H, DeMeo M, Chen JS, Mann JJ (1990) Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 15; 27(10):1143-55 (Pubitemid 20150026)
30. A Minegishi T Ishizaki 1984 Determination of free 3-Methoxy-4- Hydroxyphenylglycol with several other monoamine metabolites in plasma by high-performance liquid chromatography with ampherometric detection J Chromatogr 311 51 57 6520169 10.1016/S0378-4347(00)84690-3 1:CAS:528:DyaL2cXmt1Kis7g%3D (Pubitemid 15219653)
31. MJ Millan A Gobert F Lejeune A Newman-Tancredi JM Rivet A Auclair JL Peglion 2001 S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine J Pharmacol Exp Ther 298 2 565 580 11454918 1:CAS:528:DC%2BD3MXlsVKqsLs%3D (Pubitemid 32673407)
32. H Mitani Y Shirayama T Yamada R Kawahara 2006 Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients Prog Neuropsychopharmacol Biol Psychiatry 30 3 531 534 16414168 10.1016/j.pnpbp.2005.11.021 1:CAS:528:DC%2BD28Xjs1aitb4%3D
33. PB Mitchell GA Smythe 1991 Endocrine and amine responses to D, L-fenfluramine in normal subjects Psychiatry Res 39 2 141 153 1686811 10.1016/0165-1781(91)90083-2 1:CAS:528:DyaK38XhsVCmu74%3D
34. G Palencia C Rios J Sotelo 2001 Clomipramine increases the striatal concentrations of dopamine and homovanillic acid in rats chronically consuming alcohol J Stud Alcohol 62 6 724 729 11838906 1:STN:280:DC%2BD387gslOqtw%3D%3D (Pubitemid 34118924)
35. M Pompili G Serafini M Innamorati AM Möller-Leimkühler G Giupponi P Girardi R Tatarelli D Lester 2010 The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention Eur Arch Psychiatry Clin Neurosci 260 8 583 600 20174927 10.1007/s00406-010-0108-z
36. AW Ravna I Sylte SG Dahl 2009 Structure and localisation of drug binding sites on neurotransmitter transporters J Mol Model 15 10 1155 1164 19238460 10.1007/s00894-009-0478-1 1:CAS:528:DC%2BC3cXlslGjt7g%3D
37. HG Ruhé NS Mason AH Schene 2007 Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies Mol Psychiatry 12 4 331 359 17389902 10.1038/sj.mp.4001949 (Pubitemid 46496835)
38. FR Sallee NS Vrindavanam D Deas-Nesmith SW Carson G Sethuraman 1997 Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial Am J Psychiatry 154 5 668 673 9137123 1:STN:280:DyaK2s3ot12ruw%3D%3D (Pubitemid 27197601)
39. Sallee FR, Vrindavanam NS, Deas-Nesmith D, Odom AM, Carson SW, Sethuraman G (1998) Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response. Biol Psychiatry 1; 44(7):562-7 (Pubitemid 28496683)
40. M Santiago ER Matarredona A Machado J Cano 1998 Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum J Neurosci Res 52 5 591 598 9632315 10.1002/(SICI)1097-4547(19980601)52:5<591:: AID-JNR11>3.0.CO;2-5 1:CAS:528:DyaK1cXjsFertb4%3D (Pubitemid 28252740)
41. R Sharma JI Javaid P Janicak K Faull J Comaty JM Davis 1989 Plasma and CSF HVA before and after pharmacological treatment Psychiatry Res 28 1 97 104 2740469 10.1016/0165-1781(89)90201-1 1:STN:280:DyaL1M3pslaksA%3D%3D (Pubitemid 19123222)
42. Smith DF, Geday J (2001) PET neuroimaging of clomipramine challenge in humans: focus on the thalamus. Brain Res (16) 892(1):193-7 (Pubitemid 32126580)
43. Stanley M, Traskman-Bendz L, Dorovini-Zis K (1985) Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 7;37(14):1279-86 (Pubitemid 15013197)
44. T Suhara A Takano Y Sudo T Ichimiya M Inoue F Yasuno Y Ikoma Y Okubo 2003 High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography Arch Gen Psychiatry 60 4 386 391 12695316 10.1001/archpsyc.60.4.386 1:CAS:528:DC%2BD3sXjtleltrc%3D (Pubitemid 36402999)
45. Sweeney D, Nelson C, Bowers M, Maas J, Heninger G (1978) Delusional versus non-delusional depression. Neurochemical differences. Lancet 100-101
46. Umene-Nakano W, Yoshimura R, Ueda N, Suzuki A, Ikenouchi-Sugita A, Hori H, Otani K, Nakamura J (2009) Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism. J Psychopharmacol PMID:19825907